Education
About Us
Working with TipRanks
Follow Us
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (HK:2185)
:2185
Total Valuation
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has a market cap or net worth of HK$1.40B. The enterprise value is HK$896.82M.
Market CapHK$1.40B
Enterprise ValueHK$896.82M
Share Statistics
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has 235,703,410 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding235,703,410
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is -8.53%.
Return on Equity (ROE)-0.13
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-8.53%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee0.00
Profits Per Employee-1.40M
Employee Count63
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Shanghai Bio-Heart Biological Technology Co., Ltd. Class H is ―. Shanghai Bio-Heart Biological Technology Co., Ltd. Class H’s PEG ratio is 0.09.
PE Ratio―
PS Ratio0.00
PB Ratio0.57
Price to Fair Value0.57
Price to FCF-2.25
Price to Operating Cash Flow-29.15
PEG Ratio0.09
Income Statement
In the last 12 months, Shanghai Bio-Heart Biological Technology Co., Ltd. Class H had revenue of 0.00 and earned -87.94M in profits. Earnings per share was -0.36.
Revenue0.00
Gross Profit0.00
Operating Income-61.04M
Pretax Income-93.32M
Net Income-87.94M
EBITDA-44.54M
Earnings Per Share (EPS)-0.36
Cash Flow
In the last 12 months, operating cash flow was -59.77M and capital expenditures -23.57M, giving a free cash flow of -83.34M billion.
Operating Cash Flow-59.77M
Free Cash Flow-83.34M
Free Cash Flow per Share-0.35
Dividends & Yields
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.57
52-Week Price Change247.83%
50-Day Moving Average7.17
200-Day Moving Average4.96
Relative Strength Index (RSI)34.37
Average Volume (3m)2.14M
Important Dates
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H upcoming earnings date is Mar 27, 2026, TBA (Confirmed).
Last Earnings DateAug 26, 2025
Next Earnings DateMar 27, 2026
Ex-Dividend Date―
Financial Position
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H as a current ratio of 15.22, with Debt / Equity ratio of 1.61%
Current Ratio15.22
Quick Ratio13.81
Debt to Market Cap0.00
Net Debt to EBITDA4.36
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H EV to EBITDA ratio is -4.06, with an EV/FCF ratio of -1.08.
EV to Sales0.00
EV to EBITDA-4.06
EV to Free Cash Flow-1.08
EV to Operating Cash Flow-1.51
Balance Sheet
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has HK$312.87M in cash and marketable securities with HK$7.67M in debt, giving a net cash position of HK$305.20M billion.
Cash & Marketable SecuritiesHK$312.87M
Total DebtHK$7.67M
Net CashHK$305.20M
Net Cash Per ShareHK$1.29
Tangible Book Value Per ShareHK$1.64
Margins
Gross margin is 46.47%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin46.47%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Shanghai Bio-Heart Biological Technology Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast22.65%